Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) is a publicly traded Healthcare sector company. As of August 19, 2026, TEVA trades at $36.48 with a market cap of $42.49B and a P/E ratio of 59.65. TEVA moved +0.88% today. Year to date, TEVA is +17.21%; over the trailing twelve months it is +102.55%. Its 52-week range spans $12.47 to $37.39. Analyst consensus is strong buy with an average price target of $41.50. Rallies surfaces TEVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TEVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $36.48 |
| Market Cap | $42.49B |
| P/E Ratio | 59.65 |
| EPS | $0.62 |
| Dividend Yield | 0.09% |
| 52-Week High | $37.39 |
| 52-Week Low | $12.47 |
| Volume | 4.95M |
| Avg Volume | 0 |
| Revenue (TTM) | $14.10B |
| Net Income | $709.00M |
| Gross Margin | 64.41% |
7 analysts cover TEVA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.50.